---
schema_version: "secwatch.filing_event.v1"
accession: "0001818093-22-000166"
form_type: "8-K"
ticker: "SKIN"
cik: "0001818093"
company_name: "SkinHealth Systems Inc."
filed_at: "2022-11-08T23:59:59+00:00"
generated_at: "2026-06-22T04:23:06.381846+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# BeautyHealth Q3 net sales $88.8M (+30% YoY), raises FY net sales guidance; cuts EBITDA outlook

## Summary
- Net sales $88.8M (+30% YoY), seventh consecutive beat; raised FY2022 net sales guidance to $360-365M.
- GAAP net income $0.1M vs loss $215.1M a year ago; adjusted net income $8.0M.
- Adjusted EBITDA $16.5M (18.6% margin); FY2022 adjusted EBITDA guidance revised to $45-50M due to FX and China zero-COVID.
- Americas net sales $58.4M (+30% YoY); APAC $15.1M (+44%); EMEA $15.3M (+21%).
- Year-to-date delivery systems sold (6,447) already exceed full-year 2021 record of 6,191; total install base 24,473.

## SEC filing metadata
- accession: 0001818093-22-000166
- form_type: 8-K
- ticker: SKIN
- cik: 0001818093
- company_name: SkinHealth Systems Inc.
- filed_at: 2022-11-08T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1818093/000181809322000166/0001818093-22-000166-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1818093/000181809322000166/skin-20221108.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001818093-22-000166
- JSON: https://secwatch.observer/filing/0001818093-22-000166.json
- Plain text: https://secwatch.observer/filing/0001818093-22-000166.txt

## Key facts
- Earnings Releases
  SkinHealth Systems Inc. updated its third quarter ended September 30, 2022 guidance (raised).
  - Period: third quarter ended September 30, 2022
  - Guidance: raised
  - Result: reported results
  source text: BeautyHealth Reports Third Quarter 2022 Financial Results Net sales beat expectations for seventh consecutive quarter Company raises 2022 net sales guidance on continued momentum and strong demand, revises adjusted EBITDA guidance against a complex macro backdrop Long Beach, Calif., November 8, 2022 – The Beauty Health Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced financial results for the third quarter ended September 30, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1818093/000181809322000166/0001818093-22-000166-index.htm
- Earnings Releases
  SkinHealth Systems Inc. reported full year 2022 results: revenue $360 million to $365 million. Guidance raised.
  - Period: full year 2022
  - Revenue: $360 million to $365 million
  - Guidance: raised
  - Result: guidance update
  source text: On continued momentum and strong provider and consumer demand, the Company raised its 2022 net sales guidance to $360 million to $365 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1818093/000181809322000166/0001818093-22-000166-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.